Review
Microsatellite Instability in Human Cancer: A Prognostic Marker for Chemotherapy?

https://doi.org/10.1006/excr.1998.4299Get rights and content

Abstract

The majority of tumors associated with thenonpolyposisform of familial colorectal cancer (HNPCC) shows a specific form of genetic instability which is manifested by length alterations of mono- or dinucleotide repeat sequences [e.g., (A)nor (CA)n]. This phenomenon was termed the RER+(replication error-positive) phenotype, MSI or MIN (microsatellite instability), and found to result from defects in the cells' DNA mismatch repair system. This system recognizes and restores misincorporated bases or slippage errors which frequently occur during DNA replication. Loss of DNA mismatch repair therefore strongly accelerates the evolutionary process of mutagenesis and selection which underlies the development of cancer. In addition to mutation avoidance, DNA mismatch repair also plays a crucial role in the toxicity of a number of DNA-damaging drugs that are used in cancer chemotherapy. In experimental systems, mismatch-repair-deficient cells are highlytolerantto the methylating chemotherapeutic drugs streptozocin and temozolomide and, albeit to a lesser extent, to cisplatin and doxorubicin. These drugs are therefore expected to be less effective on mismatch-repair-deficient tumors in humans. MIN was also found in a substantial portion of sporadic (nonfamilial) human tumors. However, in many cases the extent of microsatellite instability was not as dramatic as found in HNPCC-related tumors and the underlying genetic defect is unclear. Therefore, while the mismatch repair status of tumors may become an important determinant in the choice of chemotherapeutic intervention, the significance of MIN in sporadic cancer remains elusive.

References (138)

  • N. De Wind et al.

    Inactivation of the mouseMsh2

    Cell

    (1995)
  • D.B. Zamble et al.

    Cisplatin and DNA repair in cancer chemotherapy

    Trends Biochem. Sci.

    (1995)
  • J.T. Drummond et al.

    Cisplatin and adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumor cell line

    J. Biol. Chem.

    (1996)
  • J.A. Mello et al.

    The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin

    Chem. Biol.

    (1996)
  • D. Ben-Yehuda et al.

    Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype

    Blood

    (1996)
  • P. Soares et al.

    Benign and malignant thyroid lesions show instability at microsatellite loci

    Eur. J. Cancer

    (1997)
  • L. Cawkwell et al.

    Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction

    Gastroenterology

    (1995)
  • W.S. Samowitz et al.

    Microsatellite instability in human colonic cancer is not a useful clinical indicator of familial colorectal cancer

    Gastroenterology

    (1995)
  • M. Strand et al.

    Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair

    Nature

    (1993)
  • L.A. Loeb

    Microsatellite instability: marker of a mutator phenotype in cancer

    Cancer Res.

    (1994)
  • J. Ionov et al.

    Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

    Nature

    (1993)
  • L.A. Aaltonen et al.

    Clues to the pathogenesis of familial colorectal cancer

    Science

    (1993)
  • S. Thibodeau et al.

    Microsatellite instability in cancer of the proximal colon

    Science

    (1993)
  • C.E. Bronner et al.

    Mutation in the DNA mismatch repair gene homologuehMLH1

    Nature

    (1994)
  • R.D. Kolodner et al.

    Structure of the humanMLH1mlh1

    Cancer Res.

    (1995)
  • B. Liu et al.

    hMSH2

    Cancer Res.

    (1994)
  • N.C. Nicolaides et al.

    Mutations of twoPMS

    Nature

    (1994)
  • N. Papadopoulos et al.

    Mutation of amutL

    Science

    (1994)
  • Y Akiyama et al.

    Germ-line mutation of thehMSH6/GTBP

    Cancer Res.

    (1997)
  • M. Miyaki et al.

    Germline mutation ofMSH6

    Nature Genet.

    (1997)
  • R. Kolodner

    Biochemistry and genetics of eukaryotic mismatch repair

    Genes Dev.

    (1996)
  • A. Hemminki et al.

    Loss of the wild typeMLH1

    Nature Genet.

    (1994)
  • S.-L. Lu et al.

    Loss or somatic mutations ofhMSH2hMSH2

    Jpn. J. Cancer Res.

    (1996)
  • P. Modrich

    Mechanisms and biological effects of mismatch repair

    Annu. Rev. Genet.

    (1991)
  • E.C. Friedberg et al.

    Mismatch repair

    DNA Repair and Mutagenesis

    (1995)
  • C. Rayssiguier et al.

    The barrier to recombination betweenEscherichia coliSalmonella typhimurium

    Nature

    (1989)
  • L. Worth et al.

    Mismatch repair proteins MutS and MutL inhibit RecA-catalyzed strand transfer between diverged DNAs

    Proc. Natl. Acad. Sci. USA

    (1994)
  • G.T. Marsischky et al.

    Redundancy ofSaccharomyces cerevisiae MSH3MSH6MSH2

    Genes Dev.

    (1996)
  • J.T. Drummond et al.

    Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells

    Science

    (1995)
  • F. Palombo et al.

    GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells

    Science

    (1995)
  • J.T. Drummond et al.

    DHFR/MSH3

    Proc. Natl. Acad. Sci. USA

    (1997)
  • G. Marra et al.

    Mismatch repair deficiency associated with overexpression of theMSH3

    Proc. Natl. Acad. Sci. USA

    (1998)
  • A. Umar et al.

    Functional overlap in mismatch repair by humanMSH3MSH6

    Genetics

    (1998)
  • J.I. Risinger et al.

    Mutation ofMSH3

    Nature Genet.

    (1996)
  • G.M. Li et al.

    Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs

    Proc. Natl. Acad. Sci. USA

    (1995)
  • S. Malkhosyan et al.

    Frameshift mutator mutations

    Nature

    (1996)
  • P. Karran et al.

    DNA damage tolerance, mismatch repair and genome instability

    BioEssays

    (1994)
  • P. Karran et al.

    Genomic instability and tolerance to alkylating agents

    Cancer Surv.

    (1996)
  • A. Umar et al.

    Correction of hypermutability,NNNMSH2MSH6

    Cancer Res.

    (1997)
  • M. Koi et al.

    Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reducesNNNhMLH1

    Cancer Res.

    (1994)
  • Cited by (0)

    1

    Fax: 31-20-512 1954. E-mail:[email protected].

    View full text